Immunohistochemical Identification of Early Disease Markers in Amyotrophic Lateral Sclerosis
CSEF · 2006 Biochemistry/ Molecular Biology
Overview
Objectives/Goals Amyotrophic Lateral Sclerosis (ALS or "Lou Gehrig's Disease") is a neurodegenerative disease characterized by the death of motor neurons, causing complete paralysis and death by respiratory failure within three to five years in human patients. The exact cause of motor neuron degeneration remains unknown. My project attempted to develop a means for the early detection of ALS. Methods/Materials Thus far, scientists have identified a number of genes that differ in mRNA expression between healthy and ALS mice, even before they show symptoms. As proteins are the base for cellular functions and changes at the mRNA level do not necessarily cause changes in the expression of corresponding proteins, I selected three specific proteins coded by previously identified genes for further examination. Through the application of immunohistochemistry, I compared the level of these proteins in spinal cord tissue taken from healthy and diseased mice. Results My experimental results showed that expression levels of all three proteins correlate with the known mRNA expression increase, but their temporal patterns were different. Two of the proteins tested, GFAP and Urocortin, showed significant changes only in the late stages of the disease, and may therefore not be useful for early detection of the disease. However, the remaining protein, TGFalpha, showed significant difference between healthy and diseased mice at a relatively early age. Conclusions/Discussion As TGFalpha protein is secreted from cells, it has the potential to be used for the early detection of ALS using relatively non-invasive methods. Additional research is warranted, as detection of early disease markers will be critical for the diagnosis and treatment of ALS.
Summary statement
My project attempted to find a means for the early detection of amyotrophic lateral sclerosis (ALS or "Lou Gehrig's Disease").
Help received
Used equipment and facilities of the Burnham Institute for Medical Research under the supervision of Dr. Rengang Wang.
Competition history
- CSEF 2006
Resources
Related projects
ISEF · 2024
The Relationship Between Elongator Protein 3 (ELP3) and Neurodegenerative Disease: Investigating the Neuromuscular Junction in an Elongator Mouse Model of ALS
CSEF · 2026
Predicting Amyotrophic Lateral Sclerosis (ALS) Progression: A 7-Protein Machine Learning Panel
CSEF · 2016
Diagnosing Neurodegenerative Diseases (ALS): Using Infrared Spectroscopy to Test for Neurodegeneration in C. elegans
AJAS · 2018
Searching for ALS Cures Using Accelerated Protein Dynamics Simulations of TDP-43
ISEF · 2025
The Novel Role of KRT Proteins as Biomarkers in the Dysregulated Neuroendocrine System of ALS for Early Diagnosis With PT150 as a Novel Multi-Target Neuroprotective Therapeutic
ISEF · 2021
In Amyotrophic Lateral Sclerosis (ALS) Patient Tissue, UG Rich RNA Is Not Preferentially Soluble as Predicted
ISEF · 2024
ALS-SynAegis: A Molecular Dynamics Study on TDP-43 Aggregation to Prevent Amyotrophic Lateral Sclerosis Onset
CSEF · 2017
Using PQQ Mitochondrial Biogenesis as a Therapeutic Approach towards the Treatment for Neurodegenerative Disease (ALS)
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects